Endogeneous morphine and codeine in mice — effect of muramyl dipeptide

This publication has 15 references indexed in Scilit:

• HYPOTHALAMIC-PITUITARY MEDIATED MODULATION OF IMMUNE FUNCTION: PROLACTIN AS A NEUROIMMUNE PEPTIDE
  Rheumatology, 1991
• Muramyl-dipeptide, a macrophage-derived cytokine, alters neuronal activity in hypothalamus and hippocampus but not in the dorsal raphe/periaqueductal gray of rats
  Journal of Neuroimmunology, 1990
• DIURNAL PERIODICITY OF CORTISOL SECRETION, IMMUNE REACTIVITY AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: IMPLICATIONS FOR STEROID TREATMENT
  Rheumatology, 1989
• Neuroimmune intercommunication, central opioids, and the immune response to bacterial endotoxin
  Journal of Neuroscience Research, 1988
• Evidence of an immune system to brain communication axis that affects central opioid functions: Muramyl peptides attenuate opiate withdrawal
  European Journal of Pharmacology, 1987
• Muramyl Peptides, Serotonergic System, and Sleep
  Annals of the New York Academy of Sciences, 1987
• Morphine and codeine are endogenous components of human cerebrospinal fluid
  Life Sciences, 1987
• Interleukin 1 reduces opioid binding in guinea pig brain
  Peptides, 1985
• Prolactin and Growth Hormone Release by Morphine in the Rat: Different Receptor Mechanisms
  Science, 1982
• Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
  Biochemical and Biophysical Research Communications, 1974